NEWARK, Del, May 02, 2023 (GLOBE NEWSWIRE) -- As per Future Market Insights’ latest industry analysis, the valuation for the global Vaginal Antifungals Market is estimated to reach US$ 1.14 Billion in 2023 and is projected to exhibit a CAGR of 4.5% over the forecast period, with an estimated valuation of US$ 1.76 Billion in 2033.
During the projection period, it is anticipated that the global market for Vaginal Antifungals will expand significantly. This can be attributed to the expansion of novel antifungal drug research and the global increase in healthcare spending. Additionally, the market is being driven by the increased incidence of bacterial vaginosis. In women of reproductive age, it is the most frequent source of vaginal discharge that results in fungus infections.
Rising trichomoniasis and candida occurrences are also assisting market growth for Vaginal Antifungals. The primary causes of candida growth that leads to vaginal yeast infection include a weakened immune system and the use of oral contraceptives or hormone therapy that increases estrogen levels.
For getting an overview of our report offerings – Request A Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17096
In addition, businesses are concentrating on winning clearance for innovative items that could fill unmet demands and strengthen their market position. Additionally, the growing need for better therapeutic options is spurring advancements in R&D, fresh approvals, and drug launches, opening up a lucrative window for business expansion.
Key Takeaways:
- Polyenes are the leading segment as product, and hold around 49.0% market value share in 2022, owing to less adverse effects and low product cost.
- Topical segment is set to lead in the of route of administration segment of Vaginal Antifungals market with a projected market value share of around 73.1% in 2022, owing to the high preference by doctors and effective cure for the disease.
- Bacterial Vaginosis is leading the indication segment with the significant market share of 44.9% owed to increased prevalence compared to other indications.
- By distribution channel, Gynaecology clinics held a share of around 41.4% in 2022, as patient pool largely comprises of female population who prefer to get consultation and treatment at Gynecology centers.
- North America dominated the global market with significant contribution from U.S. region. US held a value share of around 27.0% in 2022 globally, due to rising prevalence of trichomoniasis in the region.
“Rising prevalence of severe vaginal infectious disorders, increasing rate of testing and launch of Vaginal Antifungals by players will boost the global market for Vaginal Antifungals,” says an analyst at Future Market Insights.
Market Competition:
The market participants are concentrating on creating and introducing enhanced treatment drugs in order to increase the accuracy and efficiency of the operations and reduce adverse effect problems.
- Brexafemme, a high-class antifungal for the treatment of vulvovaginal candidiasis (VCC), will be commercialised and further developed by GSK plc and SCYNEXIS Inc. in 2023 under an exclusive licencing agreement. These drugs have also been approved by the FDA.
Key Players:
- Pfizer Inc.
- Bausch Health Companies Inc
- ANI Pharmaceuticals, Inc.
- Hikma Pharmaceuticals Plc
- Lupin Limited
- Mycovia Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- GSK plc.
- Others
Get a more Detailed Analysis of this Top Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-17096
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the Vaginal Antifungals market in its latest study, presenting a historical demand assessment of 2018 to 2022 and projections for 2023 to 2033. The global Vaginal Antifungals market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Key Market Segments Covered:
By Product:
- Polyenes
- Azoles
- Allylamines
- Echinocandins
- Others
By Route of Administration:
- Oral
- Topical
By Indication:
- Bacterial Vaginosis
- Candidiasis
- Trichomoniasis
- Others
Distribution Channel:
- Hospital Pharmacies
- Supermarkets/hypermarkets
- Online Pharmacies
- Gynecology Clinics
- Others
Request Report Methodology @ https://www.futuremarketinsights.com/request-report-methodology/rep-gb-17096
Table of Content (ToC):
1. Executive Summary | Vaginal Antifungals Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Recent Product Launches
4.3. Disease Epidemiology
4.4. Patient Treatment Regime
4.5. Pipeline Assessment
4.6. Regulatory Scenario
4.7. PESTLE Analysis
4.8. Porter’s Analysis
4.9. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Antifungal Drugs Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. New Product Launches / Approvals
5.2.3. Rising Prevalence of Vaginal Infectious Diseases
5.2.4. Demand for Minimally Invasive Treatment
5.2.5. High Incidence of Trichomoniasis
5.2.6. Growing Investment in Healthcare Expenditure
5.2.7. Government Support for Research and Development
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/17096
Have a Look at Related Reports of Healthcare domain:
Irradiation Apparatus Market Size: Owing to the growing support from various governmental organizations, the market is likely to propel to US$ 8.0 Billion by 2032. The trade is projected at a 3.5% CAGR during the forecast period.
Neurovascular Devices/ Interventional Neurology Market Share: Increasing demand for interventional neurology due to rising neurological disorders, which are likely to generate a neurovascular devices market growth of US$ 6.2 Billion by 2032.
Back Therapy Kits Market Demand: The global back therapy kits market was valued at US$ 3,700 Million in 2022, and is projected to reach US$ 5,800 Million by 2032 with a CAGR of 4.6%.
Necrotizing Fasciitis Treatment Market Analysis: The global necrotizing fasciitis treatment market is forecast to grow at a CAGR of 6.3% during the assessment period ranging from 2022 to 2032.
Motion Stimulation Therapy Market Forecast: During the forecast period ranging from 2022 to 2032, a CAGR of 4.1% is expected for the market, reaching US$ 1.8 Million.
Patient Portal Market Trends: The market is projected to procure US$ 22.29 Billion by 2032 while expanding at a staggering double-digit CAGR of 20% during the forecast period from 2022 to 2032.
Unilateral Biportal Endoscopy Market Overview: The global unilateral biportal endoscopy market size was valued at US$ 750 Million in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2032.
Medical Device Analytical Testing Outsourcing Market Growth: The ubiquitous medical device analytical testing outsourcing market garnered US$ 5.11 Billion in 2021, and is credibly to exhibit a CAGR of 7.18% surpassing a valuation of US$ 10.96 Billion in 2032.
Preclinical Medical Device Testing Services Market Opportunities: The global preclinical medical device testing services market garnered a market value of US$ 2.8 Billion in 2022 and is expected to accumulate a market value of US$ 6.63 Billion by registering a CAGR of 9% in the forecast period 2022 to 2032.
Bone Cement Delivery Systems Market Revenue: As per FMI, the global bone cement delivery systems market is predicted to witness US$ 830 Million in 2022 and is expected to exhibit a CAGR of 6.9% from 2022 to reach US$ 1730 Million by 2032.
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
